Privia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum Sells 2,252 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum sold 2,252 shares of the business’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total value of $41,481.84. Following the completion of the sale, the executive vice president now directly owns 103,862 shares in the company, valued at $1,913,138.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Privia Health Group Trading Up 1.8 %

Shares of NASDAQ PRVA opened at $18.74 on Friday. Privia Health Group, Inc. has a 12-month low of $17.54 and a 12-month high of $30.15. The firm has a market capitalization of $2.22 billion, a price-to-earnings ratio of 98.64, a price-to-earnings-growth ratio of 2.52 and a beta of 0.81. The firm has a 50 day moving average of $19.64 and a 200 day moving average of $21.14.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Tuesday, February 27th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. The company had revenue of $440.80 million during the quarter, compared to the consensus estimate of $425.81 million. During the same period in the prior year, the business posted $0.14 earnings per share. Privia Health Group’s revenue for the quarter was up 21.0% compared to the same quarter last year. Sell-side analysts predict that Privia Health Group, Inc. will post 0.26 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Norges Bank bought a new stake in Privia Health Group during the 4th quarter worth approximately $27,959,000. Riverbridge Partners LLC raised its position in shares of Privia Health Group by 17.5% during the 1st quarter. Riverbridge Partners LLC now owns 5,399,662 shares of the company’s stock valued at $105,779,000 after purchasing an additional 804,304 shares during the period. Avidity Partners Management LP lifted its stake in shares of Privia Health Group by 43.1% during the 3rd quarter. Avidity Partners Management LP now owns 1,545,100 shares of the company’s stock valued at $35,537,000 after buying an additional 465,294 shares in the last quarter. Northern Trust Corp lifted its stake in shares of Privia Health Group by 28.7% during the 3rd quarter. Northern Trust Corp now owns 1,344,327 shares of the company’s stock valued at $30,920,000 after buying an additional 299,395 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in Privia Health Group by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company’s stock worth $259,740,000 after buying an additional 274,345 shares during the period. 94.48% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. TD Cowen lowered their price target on Privia Health Group from $30.00 to $26.00 and set an “outperform” rating for the company in a research report on Friday, March 1st. Jefferies Financial Group assumed coverage on shares of Privia Health Group in a report on Monday, February 26th. They issued a “buy” rating and a $25.00 price objective for the company. Citigroup assumed coverage on Privia Health Group in a research note on Monday, April 22nd. They set a “buy” rating and a $25.00 target price on the stock. Canaccord Genuity Group decreased their price target on Privia Health Group from $41.00 to $37.00 and set a “buy” rating for the company in a research note on Tuesday, March 19th. Finally, Evercore ISI reduced their price objective on Privia Health Group from $26.00 to $25.00 and set an “outperform” rating for the company in a report on Wednesday, February 28th. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $27.62.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.